71P the Efficacy of Palbociclib and Ribociclib in the First-Line Treatment of Metastatic Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer in Male Patients: A Turkish Oncology Group (TOG) Study
ESMO Open(2024)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要